These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 26036334)

  • 1. Approaches for estimating minimal clinically important differences in systemic lupus erythematosus.
    Rai SK; Yazdany J; Fortin PR; Aviña-Zubieta JA
    Arthritis Res Ther; 2015 Jun; 17(1):143. PubMed ID: 26036334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus.
    Goligher EC; Pouchot J; Brant R; Kherani RB; Aviña-Zubieta JA; Lacaille D; Lehman AJ; Ensworth S; Kopec J; Esdaile JM; Liang MH
    J Rheumatol; 2008 Apr; 35(4):635-42. PubMed ID: 18322987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal clinically important differences of disease activity indices in childhood-onset systemic lupus erythematosus.
    Brunner HI; Higgins GC; Klein-Gitelman MS; Lapidus SK; Olson JC; Onel K; Punaro M; Ying J; Giannini EH
    Arthritis Care Res (Hoboken); 2010 Jul; 62(7):950-9. PubMed ID: 20589695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of minimum clinically important difference (MCID) in pain, disability, and quality of life after revision fusion for symptomatic pseudoarthrosis.
    Parker SL; Adogwa O; Mendenhall SK; Shau DN; Anderson WN; Cheng JS; Devin CJ; McGirt MJ
    Spine J; 2012 Dec; 12(12):1122-8. PubMed ID: 23158968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
    American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
    Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing minimal clinically important difference: consensus or conundrum?
    Gatchel RJ; Mayer TG
    Spine J; 2010 Apr; 10(4):321-7. PubMed ID: 20362248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the minimum clinically important difference in pain, disability, and quality of life after anterior cervical discectomy and fusion: clinical article.
    Parker SL; Godil SS; Shau DN; Mendenhall SK; McGirt MJ
    J Neurosurg Spine; 2013 Feb; 18(2):154-60. PubMed ID: 23176164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the minimal clinically important difference for seven measures of fatigue in Swedish patients with systemic lupus erythematosus.
    Pettersson S; Lundberg IE; Liang MH; Pouchot J; Henriksson EW
    Scand J Rheumatol; 2015 May; 44(3):206-10. PubMed ID: 25656604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimum clinically important difference in pain, disability, and quality of life after neural decompression and fusion for same-level recurrent lumbar stenosis: understanding clinical versus statistical significance.
    Parker SL; Mendenhall SK; Shau DN; Adogwa O; Anderson WN; Devin CJ; McGirt MJ
    J Neurosurg Spine; 2012 May; 16(5):471-8. PubMed ID: 22324801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing minimal clinically important differences for the quality of life scale QLICD-SLE for patients with systemic lupus erythematosus based on ROC curve.
    Liu Y; Xue H; Wong W; Ding H; Chen M; Xie T; Wan C
    Sci Rep; 2024 Sep; 14(1):20982. PubMed ID: 39251635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis.
    Parker SL; Adogwa O; Paul AR; Anderson WN; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 May; 14(5):598-604. PubMed ID: 21332281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
    Castrejón I; Tani C; Jolly M; Huang A; Mosca M
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimum clinically important difference in lumbar spine surgery patients: a choice of methods using the Oswestry Disability Index, Medical Outcomes Study questionnaire Short Form 36, and pain scales.
    Copay AG; Glassman SD; Subach BR; Berven S; Schuler TC; Carreon LY
    Spine J; 2008; 8(6):968-74. PubMed ID: 18201937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing the minimal clinically important difference of the Barthel Index in stroke patients.
    Hsieh YW; Wang CH; Wu SC; Chen PC; Sheu CF; Hsieh CL
    Neurorehabil Neural Repair; 2007; 21(3):233-8. PubMed ID: 17351082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal Clinically Important Difference (MCID) in Patient-Reported Outcome Measures for Neurological Conditions: Review of Concept and Methods.
    Mishra B; Sudheer P; Agarwal A; Srivastava MVP; Nilima ; Vishnu VY
    Ann Indian Acad Neurol; 2023; 26(4):334-343. PubMed ID: 37970301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of minimum clinically important difference in pain, disability, and quality of life after extension of fusion for adjacent-segment disease.
    Parker SL; Mendenhall SK; Shau D; Adogwa O; Cheng JS; Anderson WN; Devin CJ; McGirt MJ
    J Neurosurg Spine; 2012 Jan; 16(1):61-7. PubMed ID: 21962034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
    Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
    J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement study.
    Uhrenholt L; Høstgaard S; Pedersen JF; Christensen R; Dreyer L; Leffers HCB; Taylor PC; Strand V; Jacobsen S; Voss A; Gregersen JW; Kristensen S
    Lupus; 2021 Nov; 30(13):2124-2134. PubMed ID: 34719299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of minimum clinically important difference for assessing patients with subaxial degenerative cervical spine disease: statistical versus substantial clinical benefit.
    Auffinger B; Lam S; Shen J; Thaci B; Roitberg BZ
    Acta Neurochir (Wien); 2013 Dec; 155(12):2345-54; discussion 2355. PubMed ID: 24136679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a consensus-based minimal clinically important difference (MCID) threshold using an objective functional external anchor.
    Gatchel RJ; Mayer TG; Choi Y; Chou R
    Spine J; 2013 Aug; 13(8):889-93. PubMed ID: 23523434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.